VALT-T 0.35 MART-T -0.05 VIDY-T 0.24 RPRX-Q 0.49 NCSM-Q -0.29 HRTG-N 0.24 BA-N 1.33
King Pharmaceuticals (KG-N)

King Pharmaceuticals (KG-N)

0 watching

0.00
0.00 (0.00%) 1d
0

Related posts

Nervous markets await Nvidia
BUY

King Pharmaceuticals(KG-N)

Apr 30, 2004
A potential takeover play. Has been a bit undermanaged and is very cheap.
David KingDavid King
Unknown
Unlock Rating
$17.250

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

King Pharmaceuticals(KG-N)

Dec 19, 2003
Technical support is $12.75. A lot of upside potential. Fair market value is $35/40. However, earnings forecast trend is in a decline.
Ross HealyRoss Healy
Unknown
Unlock Rating
$14.680

Stock price when the opinion was issued

biotechnology pharmaceutical
PAST TOP PICK

King Pharmaceuticals(KG-N)

Sep 25, 2003
(A top pick Aug 12/03. Up 3%.) Still likes. An outstanding value for investors to focus on.
Brian Acker, CABrian Acker, CA
Owned
Unlock Rating
$15.250

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

King Pharmaceuticals(KG-N)

Sep 15, 2003
Has great value. US Healthcare looks very inexpensive.
Brian Acker, CABrian Acker, CA
Owned
Unlock Rating
$16.120

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

King Pharmaceuticals(KG-N)

Sep 03, 2003
Will be volatile. An OK company at a bargain price. Good risk/reward.
Peter Arender, CFAPeter Arender, CFA
Owned
Unlock Rating
$14.200

Stock price when the opinion was issued

biotechnology pharmaceutical
WEAK BUY

King Pharmaceuticals(KG-N)

Aug 22, 2003
Generic drug makers have been on quite a role.A good group to have exposure to.This company has FCC and business model problems.Risky.
Matt BaraschMatt Barasch
Unknown
Unlock Rating
$13.970

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

King Pharmaceuticals(KG-N)

Aug 12, 2003
(Was a top pick on July 14, 2003.Up 15%.)Still likes.Good earnings. Came out with a relatively good performance report.Got hit by a sudden move of defense money moving into cyclical areas.Got too cheap.
Brian Acker, CABrian Acker, CA
Owned
Unlock Rating
$13.920

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

King Pharmaceuticals(KG-N)

Jul 14, 2003
Systems indicate a top pick. Cheap and has earnings.
Brian Acker, CABrian Acker, CA
Unknown
Unlock Rating
$16.250

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

King Pharmaceuticals(KG-N)

Nov 07, 2002
Fundamentally should be good, but the stock languishes.
Brian Acker, CABrian Acker, CA
Unknown
Unlock Rating
$15.910

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

King Pharmaceuticals(KG-N)

Aug 16, 2002
Cheap/ Good growth prospects. Only own a small portion in your portfolio.
Robert FloydRobert Floyd
Unknown
Unlock Rating
$19.380

Stock price when the opinion was issued

biotechnology pharmaceutical
Showing 1 to 10 of 10 entries
  • «
  • ‹
  • 1
  • ›
  • »

King Pharmaceuticals(KG-N) Rating

Ranking : 1 out of 5

Star iconStar empty iconStar empty iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for King Pharmaceuticals is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

King Pharmaceuticals(KG-N) Frequently Asked Questions

What is King Pharmaceuticals stock symbol?

King Pharmaceuticals is a OTC stock, trading under the symbol KG-N on the (). It is usually referred to as or KG-N

Is King Pharmaceuticals a buy or a sell?

In the last year, there was no coverage of King Pharmaceuticals published on Stockchase.

Is King Pharmaceuticals a good investment or a top pick?

King Pharmaceuticals was recommended as a Top Pick by on . Read the latest stock experts ratings for King Pharmaceuticals.

Why is King Pharmaceuticals stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is King Pharmaceuticals worth watching?

In the last year 0 stock analysts on Stockchase covered King Pharmaceuticals. The stock is worth watching.

What is King Pharmaceuticals stock price?

On , King Pharmaceuticals (KG-N) stock closed at a price of $.

Build our watch list

Sign in to track investments
you care about

Latest Buy Signals

CMNY-T 0.015$50.105
HEQL-T 0.44$27
DXP-T -0.03$23.21
ZMMK-T -0.01$49.89
PYF-T 0.01$17.39

Today's Top Picks

VALT-T 0.35$40.95
MART-T -0.05$22.85
VIDY-T 0.24$35.47
RPRX-Q 0.49$33.59
NCSM-Q -0.29$32.42

Popular Articles

Latest Sell Signals

HPYT-T 0.02$9.2
RHT-X 0.005$0.215
GOOG-Q -1.04$154.71
GOOG-Q -1.04$154.71
T-T 1.42$22.22

Most Recent Experts

Daniel Straus

Daniel Straus

National Bank Financial

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase Insights

Stockchase Insights

5i Research

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: hello@stockchase.com.

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© Stockchase Inc. by Wealthica